Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saredutant in Generalized Anxiety Disorder
NCT00390533Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2006
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of saredutant in generalized anxiety disorder (GAD), sponsored by Sanofi. Started Sep 2006; status: completed.
02
Drugs
saredutant
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00390533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00390533.